Literature DB >> 28084826

The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air.

Spyros A Papiris1, Konstantinos Kagouridis1, Likurgos Kolilekas1, Anna Karakatsani1, Ioanna Korbila1, Paschalina Giouleka1, Georgia Papadaki1, Maria Maniati1, Demosthenes Bouros1, Effrosyni D Manali1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28084826     DOI： 10.1164/rccm.201607-1426LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Yaniv Dotan; William B Shapiro; Eneida Male; Eduardo C Dominguez; Amandeep Aneja; Zhao Huaqing; Chandra Dass; Kartik Shenoy; Nathaniel Marchetti; Francis C Cordova; Gerard J Criner; A James Mamary
Journal:  ERJ Open Res       Date:  2020-10-05

Review 2.  Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?

Authors:  Alessandro Marchioni; Roberto Tonelli; Lorenzo Ball; Riccardo Fantini; Ivana Castaniere; Stefania Cerri; Fabrizio Luppi; Mario Malerba; Paolo Pelosi; Enrico Clini
Journal:  Crit Care       Date:  2018-03-23       Impact factor: 9.097

3.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis With Pirfenidone and Nintedanib: A Friend or Foe.

Authors:  Mohit Kaushal; Dhruv Talwar; Deepak Prajapat; Sunil Kumar; Sourya Acharya; Deepak Talwar
Journal:  Cureus       Date:  2022-02-25

4.  IPF-Acute Exacerbations: Advances and Future Perspectives.

Authors:  Spyros A Papiris; Lykourgos Kolilekas; Konstantinos Kagouridis; Maria Maniati; Effrosyni D Manali
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.